Barclays
OFIX icon

Barclays’s Orthofix Medical OFIX Stock Holding History

Barclays’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-5,000
Closed -$262K – 7233
2018
Q4 		$262K Buy
+5,000
New +$284K ﹤0.01% 4382
2014
Q2 		– Sell
-65,000
Closed -$1.95M – 7747
2014
Q1 		$1.95M Buy
+65,000
New +$1.5M ﹤0.01% 2577

Other funds holding OFIX

ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Barclays's OFIX Position: Q1 2026 in Review

Barclays reduced its Orthofix Medical (OFIX) stake by 58% in Q1 2026, selling an estimated $650K and leaving 35,987 shares worth $413K. The position accounts for ﹤0.01% of the portfolio, ranked #3294.

Barclays first reported a position in OFIX in Q2 2013 and has held it in 51 quarters since. The position peaked at $3.4M in Q2 2013. 147 funds tracked by Wall St. Rank hold OFIX as of Q1 2026.

  • Barclays held 35,987 shares of Orthofix Medical worth $413K as of Q1 2026.
  • Barclays sold 49,240 Orthofix Medical shares in Q1 2026, an estimated $650K.
  • Orthofix Medical made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3294 holding.
  • Barclays first reported a position in Orthofix Medical in Q2 2013 and has held it in 51 quarters since.
  • Barclays's Orthofix Medical position peaked at $3.4M in Q2 2013.
  • 147 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.